IT1400311B1 - Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso. - Google Patents
Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso.Info
- Publication number
- IT1400311B1 IT1400311B1 ITRM2010A000232A ITRM20100232A IT1400311B1 IT 1400311 B1 IT1400311 B1 IT 1400311B1 IT RM2010A000232 A ITRM2010A000232 A IT RM2010A000232A IT RM20100232 A ITRM20100232 A IT RM20100232A IT 1400311 B1 IT1400311 B1 IT 1400311B1
- Authority
- IT
- Italy
- Prior art keywords
- angiotensin
- antagonists
- inhibitors
- receptor
- association
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (24)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM2010A000232A IT1400311B1 (it) | 2010-05-10 | 2010-05-10 | Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso. |
SG2012082319A SG185474A1 (en) | 2010-05-10 | 2011-05-09 | Association of xanthine oxidase inhibitors and angiotensin ii receptor antagonists and use thereof |
CN2011800232573A CN103037861A (zh) | 2010-05-10 | 2011-05-09 | 黄嘌呤氧化酶抑制剂与血管紧张素ii受体拮抗剂的组合及其用途 |
CA2798573A CA2798573A1 (en) | 2010-05-10 | 2011-05-09 | Association of xanthine oxidase inhibitors and angiotensin ii receptor antagonists and use thereof |
ARP110101590A AR081376A1 (es) | 2010-05-10 | 2011-05-09 | Combinacion de inhibidores de xantina oxidasa y antagonistas del receptor de angiotensina ii y su uso |
PE2012002151A PE20130812A1 (es) | 2010-05-10 | 2011-05-09 | Combinacion de inhibidor de xantina oxidasa y antagonistas del receptor de angiotensina ii |
JP2013509533A JP2013526503A (ja) | 2010-05-10 | 2011-05-09 | キサンチンオキシダーゼ阻害剤とアンジオテンシンii受容体アンタゴニストとの合剤およびその使用 |
KR1020127032188A KR20130101447A (ko) | 2010-05-10 | 2011-05-09 | 크산틴 옥시다아제 억제제 및 안지오텐신 ⅱ 수용체 길항제 및 이의 용도 |
EA201201528A EA201201528A1 (ru) | 2010-05-10 | 2011-05-09 | Комбинация ингибиторов ксантиноксидазы и антагонистов рецепторов ангиотензина-ii и ее применение |
MX2012013054A MX2012013054A (es) | 2010-05-10 | 2011-05-09 | Combinacion de inhibidores de xantina oxidasa y antagonistas del receptor de angiotensina ii y su uso. |
BR112012028887A BR112012028887A2 (pt) | 2010-05-10 | 2011-05-09 | associação de inibidores de xantina oxidase e antagonistas receptores de angiotensina ii e uso dos mesmos |
US13/697,066 US20130131128A1 (en) | 2010-05-10 | 2011-05-09 | Association of xanthine oxidase inhibitors and angiotensin ii receptor antagonists and use thereof |
NZ603414A NZ603414A (en) | 2010-05-10 | 2011-05-09 | Association of xanthine oxidase inhibitors and angiotensin ii receptor antagonists and use thereof |
EP11718734.4A EP2568982B1 (en) | 2010-05-10 | 2011-05-09 | Association of xanthine oxidase inhibitors and angiotensin ii receptor antagonists and use thereof |
MA35430A MA34297B1 (fr) | 2010-05-10 | 2011-05-09 | Association d'inhibiteurs de la xanthine oxydase et d'antagonistes du récepteur de l'angiotensine ii et son utilisation |
TW100116119A TW201206432A (en) | 2010-05-10 | 2011-05-09 | Association of xanthine oxidase inhibitors and angiotensin II receptor antagonists and use thereof |
PCT/EP2011/057438 WO2011141431A1 (en) | 2010-05-10 | 2011-05-09 | Association of xanthine oxidase inhibitors and angiotensin ii receptor antagonists and use thereof |
AU2011252151A AU2011252151A1 (en) | 2010-05-10 | 2011-05-09 | Association of xanthine oxidase inhibitors and angiotensin II receptor antagonists and use thereof |
IL222927A IL222927A0 (en) | 2010-05-10 | 2012-11-08 | Association of xanthine oxidase inhibitors and angiotensin ii receptor antagonists and use thereof |
CL2012003143A CL2012003143A1 (es) | 2010-05-10 | 2012-11-08 | Una combinacion de a) un inhibidor de la xantina oxidasa, febuxostat y b) al menos un antagonista del receptor de angiotensina ii, el cual es olmesartan medoxomil; composicion farmaceutica que los comprende; metodo de preparacion; y uso para tratar la hipertension, sola o asociada con hiperuricemia. |
ZA2012/09295A ZA201209295B (en) | 2010-05-10 | 2012-12-07 | Association of xanthine oxidase inhibitors and angiotensin ii receptor antagonists and use thereof |
ECSP12012332 ECSP12012332A (es) | 2010-05-10 | 2012-12-10 | Asociación de inhibidores de la xantina oxidasa y la instatina y su uso |
CO12223245A CO6640306A2 (es) | 2010-05-10 | 2012-12-10 | Combinación de inhibidores de xantina oxidasa y antagonistas del receptor de angiotensina ii y su uso |
ECSP12012331 ECSP12012331A (es) | 2010-05-10 | 2012-12-10 | Combinacion de inhibidores de xantina oxidasa y antagonistas del receptor de angiotensina ii y su uso |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM2010A000232A IT1400311B1 (it) | 2010-05-10 | 2010-05-10 | Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso. |
Publications (2)
Publication Number | Publication Date |
---|---|
ITRM20100232A1 ITRM20100232A1 (it) | 2011-11-11 |
IT1400311B1 true IT1400311B1 (it) | 2013-05-24 |
Family
ID=42753377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITRM2010A000232A IT1400311B1 (it) | 2010-05-10 | 2010-05-10 | Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso. |
Country Status (23)
Country | Link |
---|---|
US (1) | US20130131128A1 (it) |
EP (1) | EP2568982B1 (it) |
JP (1) | JP2013526503A (it) |
KR (1) | KR20130101447A (it) |
CN (1) | CN103037861A (it) |
AR (1) | AR081376A1 (it) |
AU (1) | AU2011252151A1 (it) |
BR (1) | BR112012028887A2 (it) |
CA (1) | CA2798573A1 (it) |
CL (1) | CL2012003143A1 (it) |
CO (1) | CO6640306A2 (it) |
EA (1) | EA201201528A1 (it) |
EC (2) | ECSP12012331A (it) |
IL (1) | IL222927A0 (it) |
IT (1) | IT1400311B1 (it) |
MA (1) | MA34297B1 (it) |
MX (1) | MX2012013054A (it) |
NZ (1) | NZ603414A (it) |
PE (1) | PE20130812A1 (it) |
SG (1) | SG185474A1 (it) |
TW (1) | TW201206432A (it) |
WO (1) | WO2011141431A1 (it) |
ZA (1) | ZA201209295B (it) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3028371B1 (fr) * | 2014-11-06 | 2016-11-18 | Bull Sas | Procede de surveillance et de controle deportes d'un cluster utilisant un reseau de communication de type infiniband et programme d'ordinateur mettant en oeuvre ce procede |
KR102284764B1 (ko) | 2020-07-08 | 2021-08-04 | 주식회사 우드메탈 | 멀티빔구조를 통한 부속의 결속이 용이한 칸막이 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU645867B2 (en) | 1990-11-30 | 1994-01-27 | Teijin Pharma Limited | 2-arylthiazole derivative and pharmaceutical composition containing the same |
IE920540A1 (en) | 1991-02-21 | 1992-08-26 | Sankyo Co | 1-biphenylmethylimidazole derivatives, their preparation and¹their therapetuic use |
EP1020454B2 (en) | 1998-06-19 | 2013-01-23 | Teijin Pharma Limited | Polymorphic modifications of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazole-carboxylic acid and processes for the preparation thereof |
EP1336407B1 (en) | 2000-11-21 | 2006-05-03 | Sankyo Company, Limited | Composition containing an angiotensin ii receptor antagonist and a diuretic and its use for the treatment of hypertension |
US20040122067A1 (en) | 2002-12-20 | 2004-06-24 | Lin Zhao | Treatment of chronic heart failure |
AU2004208615C1 (en) | 2003-01-31 | 2010-05-13 | Daiichi Sankyo Company, Limited | Medicine for prevention of and treatment for arteriosclerosis and hypertension |
WO2005027887A2 (en) * | 2003-09-17 | 2005-03-31 | Cardimone Pharma Corporation | Methods and compositions for improving endothelial function |
JP5242393B2 (ja) * | 2005-08-03 | 2013-07-24 | タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド | 高血圧症の治療方法 |
CA2630639A1 (en) | 2005-11-21 | 2007-05-31 | Tap Pharmaceutical Products, Inc. | Treatment of qt interval prolongation and diseases associated therewith |
KR20160031040A (ko) | 2006-11-13 | 2016-03-21 | 다케다 파마슈티칼스 유에스에이, 인코포레이티드 | 크산틴 옥시도리덕타아제 억제제를 사용하여 신장 기능을 보존하는 방법 |
-
2010
- 2010-05-10 IT ITRM2010A000232A patent/IT1400311B1/it active
-
2011
- 2011-05-09 WO PCT/EP2011/057438 patent/WO2011141431A1/en active Application Filing
- 2011-05-09 SG SG2012082319A patent/SG185474A1/en unknown
- 2011-05-09 CA CA2798573A patent/CA2798573A1/en not_active Abandoned
- 2011-05-09 NZ NZ603414A patent/NZ603414A/en not_active IP Right Cessation
- 2011-05-09 MX MX2012013054A patent/MX2012013054A/es not_active Application Discontinuation
- 2011-05-09 EA EA201201528A patent/EA201201528A1/ru unknown
- 2011-05-09 PE PE2012002151A patent/PE20130812A1/es not_active Application Discontinuation
- 2011-05-09 CN CN2011800232573A patent/CN103037861A/zh active Pending
- 2011-05-09 EP EP11718734.4A patent/EP2568982B1/en not_active Not-in-force
- 2011-05-09 TW TW100116119A patent/TW201206432A/zh unknown
- 2011-05-09 AR ARP110101590A patent/AR081376A1/es unknown
- 2011-05-09 BR BR112012028887A patent/BR112012028887A2/pt not_active IP Right Cessation
- 2011-05-09 KR KR1020127032188A patent/KR20130101447A/ko not_active Application Discontinuation
- 2011-05-09 AU AU2011252151A patent/AU2011252151A1/en not_active Abandoned
- 2011-05-09 US US13/697,066 patent/US20130131128A1/en not_active Abandoned
- 2011-05-09 JP JP2013509533A patent/JP2013526503A/ja not_active Abandoned
- 2011-05-09 MA MA35430A patent/MA34297B1/fr unknown
-
2012
- 2012-11-08 CL CL2012003143A patent/CL2012003143A1/es unknown
- 2012-11-08 IL IL222927A patent/IL222927A0/en unknown
- 2012-12-07 ZA ZA2012/09295A patent/ZA201209295B/en unknown
- 2012-12-10 CO CO12223245A patent/CO6640306A2/es not_active Application Discontinuation
- 2012-12-10 EC ECSP12012331 patent/ECSP12012331A/es unknown
- 2012-12-10 EC ECSP12012332 patent/ECSP12012332A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2013526503A (ja) | 2013-06-24 |
IL222927A0 (en) | 2012-12-31 |
EA201201528A1 (ru) | 2013-04-30 |
AU2011252151A1 (en) | 2012-11-29 |
EP2568982A1 (en) | 2013-03-20 |
EP2568982B1 (en) | 2014-04-02 |
ITRM20100232A1 (it) | 2011-11-11 |
TW201206432A (en) | 2012-02-16 |
KR20130101447A (ko) | 2013-09-13 |
PE20130812A1 (es) | 2013-08-08 |
BR112012028887A2 (pt) | 2016-07-26 |
MX2012013054A (es) | 2013-03-05 |
MA34297B1 (fr) | 2013-06-01 |
US20130131128A1 (en) | 2013-05-23 |
SG185474A1 (en) | 2012-12-28 |
ECSP12012331A (es) | 2013-02-28 |
AR081376A1 (es) | 2012-08-29 |
CN103037861A (zh) | 2013-04-10 |
CO6640306A2 (es) | 2013-03-22 |
ZA201209295B (en) | 2013-08-28 |
CA2798573A1 (en) | 2011-11-17 |
ECSP12012332A (es) | 2013-02-28 |
CL2012003143A1 (es) | 2013-06-21 |
NZ603414A (en) | 2014-03-28 |
WO2011141431A1 (en) | 2011-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1008060A2 (pt) | Agonistas e antagonistas do receptor s1p5, e métodos de uso do mesmo. | |
SMT201600098B (it) | Antagonisti del complemento e loro usi | |
SMT201500213B (it) | Alcune triazolopirazine, loro composizioni e metodi d'uso | |
SMT201500206B (it) | Composti spiro-ossindolici e loro uso come agenti terapeutici | |
SMT201700064B (it) | Antagonisti di d2, metodi di sintesi e metodi di uso | |
SMT201400181B (it) | Composizioni per vasocostrizione e metodi d'uso | |
SMT201600078B (it) | Antagonista del recettore per cgrp | |
HK1151218A1 (en) | Notch-binding agents and antagonists and methods of use thereof notch- | |
ECSP12012034A (es) | Antagonistas de pcsk9 | |
EA200870409A1 (ru) | Антагонисты киназы pi3 | |
IT1398930B1 (it) | Formulazioni farmaceutiche bistrato contenenti agonisti ed antagonisti oppioidi. | |
SMT201400114B (it) | Derivati di 2-arilimidazolo come inibitori dell'enzima pde10a | |
DK2443104T3 (da) | Disubstituerede phthalazin-hedgehog-sti-antagonister | |
EA201290355A1 (ru) | Спиропиперидиновые соединения в качестве антагонистов рецептора orl-1 | |
DK2821407T3 (da) | Piperidinoncarboxamidazaindan-cgrp receptorantagonister | |
BRPI1012097A2 (pt) | antagonistas e antagonistas inversos de histamina h3 e métodos de uso dos mesmos. | |
MA34075B1 (fr) | Composition pharmaceutique comprenant un dérivé pyrimidineone | |
IT1403847B1 (it) | Composizioni farmaceutiche comprendenti rifaximina e loro uso. | |
SMT201500296B (it) | Antagonisti del recettore trpm8 | |
CL2008001795A1 (es) | Uso de un antagonista par1 en el tratamiento de la fibrilacion atrial. | |
CL2013000502A1 (es) | Compuestos derivados de-2-(1-(2(2carbonil - etil) bencil) pirrolidin-2il)-n- alquiloxazol -4 carboxamida; uso en el tratamiento de enfermedades involucrada con la respuesta anttinflamatoria en receptores de prostaglandina. | |
BRPI1009257A2 (pt) | antagonista receptor de mineralocorticoide e métodos de uso. | |
DK2287163T3 (da) | 2-amino-3-sulfonyl-tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidinantagonister af serotonin 5-ht6-receptorer, fremgangsmåder til fremstillingen og anvendelse deraf | |
IT1400311B1 (it) | Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso. | |
BRPI0923878A2 (pt) | Inibidores de giyt1 bicíclicos 3.1.0 e métodos de produção e uso dos mesmos. |